CVE-2020-3228

Cisco IOS, IOS XE, and NX-OS Software Security Group Tag Exchange Protocol Denial of Service Vulnerability

Description

A vulnerability in Security Group Tag Exchange Protocol (SXP) in Cisco IOS Software, Cisco IOS XE Software, and Cisco NX-OS Software could allow an unauthenticated, remote attacker to cause the affected device to reload, resulting in a denial of service (DoS) condition. The vulnerability exists because crafted SXP packets are mishandled. An attacker could exploit this vulnerability by sending specifically crafted SXP packets to the affected device. A successful exploit could allow the attacker to cause the affected device to reload, resulting in a DoS condition.

Category

8.6
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 1.65% Top 20%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS 15.3(2)T
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-3228?
CVE-2020-3228 has been scored as a high severity vulnerability.
How to fix CVE-2020-3228?
To fix CVE-2020-3228, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-3228 being actively exploited in the wild?
It is possible that CVE-2020-3228 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-3228?
CVE-2020-3228 affects Cisco Cisco IOS 15.3(2)T.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.